← Evidence map

ReviewFrontiers in microbiology2026

Tirzepatide and the gut microbiota-obesity axis: metabolic mechanisms and therapeutic perspectives.

Santiago Cadena-Ullauri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42499664